Form 4: Apyx Medical Corp Director Wendy Levine Acquires Stock Options

Director Wendy Levine acquired 50,000 stock options in Apyx Medical Corp as part of the Director Compensation Program.

Summary

• Wendy Levine, a director of Apyx Medical Corp, acquired 50,000 stock options on January 15, 2025.
• The options were granted under the Issuer's Director Compensation Program, as amended.
• The exercise price is $1.42 per share.
• The options vest ratably over 12 months and become fully vested on January 15, 2026.
• The options expire on January 15, 2035.

Sentiment

Score: 7

Explanation: The granting of stock options to a director is generally viewed as a neutral to slightly positive event, indicating alignment of interests with shareholders.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard practice for compensating directors of publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include stock options to align the interests of directors with those of shareholders.
• The vesting schedule of 12 months is a common practice in the industry.
• The exercise price being equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue is a common practice.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates